TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma Journal Article
| Authors: | Casey, D. L.; Pitter, K. L.; Wexler, L. H.; Slotkin, E. K.; Gupta, G. P.; Wolden, S. L. |
| Article Title: | TP53 mutations increase radioresistance in rhabdomyosarcoma and Ewing sarcoma |
| Abstract: | Background: p53 plays a key role in the DNA repair process and response to ionising radiation. We sought to determine the clinical phenotype of TP53 mutations and p53 pathway alterations in patients with rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) treated with radiation. Methods: Of patients with available genomic sequencing, we identified 109 patients with RMS and ES treated to a total of 286 radiation sites. We compared irradiated tumour control among tumours with TP53 mutations (n = 40) to those that were TP53 wild-type (n = 246). We additionally compared irradiated tumour control among tumours with any p53 pathway alteration (defined as tumours with TP53 mutations or TP53 wild-type tumours identified to have MDM2/4 amplification and/or CDKN2A/B deletion, n = 78) to those without such alterations (n = 208). Results: The median follow-up was 26 months from radiation. TP53 mutations were associated with worse irradiated tumour control among the entire cohort (hazard ratio, HR = 2.8, P < 0.0001). Tumours with any p53 pathway alteration also had inferior irradiated tumour control (HR = 2.0, P = 0.003). On multivariable analysis, after controlling for tumour histology, intent of radiation, presence of gross disease, and biologically effective dose, TP53 mutations continued to be associated with a radioresistant phenotype (HR = 7.1, P < 0.0001). Conclusions: Our results show that TP53 mutations are associated with increased radioresistance in RMS and ES. Novel strategies to overcome this radioresistance are important for improved outcomes in p53 disruptive RMS and ES. © 2021, The Author(s), under exclusive licence to Springer Nature Limited. |
| Journal Title: | British Journal of Cancer |
| Volume: | 125 |
| Issue: | 4 |
| ISSN: | 0007-0920 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2021-08-17 |
| Start Page: | 576 |
| End Page: | 581 |
| Language: | English |
| DOI: | 10.1038/s41416-021-01438-2 |
| PUBMED: | 34017087 |
| PROVIDER: | scopus |
| PMCID: | PMC8368014 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 September 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work